Results 191 to 200 of about 16,179 (202)

Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology

JAMA Neurology, 2019
Michael G Heckman, Catherine Labbé, Alexandra I Soto   +2 more
exaly  

Social cognitive deficits and their neural correlates in progressive supranuclear palsy

Brain, 2012
Boyd C P Ghosh, Andrew J Calder, Polly V Peers   +2 more
exaly  

Prevalence of progressive supranuclear palsy in Yonago, Japan

Movement Disorders, 2004
Masayoshi Kusumi
exaly  

Methysergide in progressive supranuclear palsy

Neurology, 1985
A S, Duncombe, A J, Lees
openaire   +2 more sources

Pharmacological Therapy in Progressive Supranuclear Palsy

Archives of Neurology, 1998
Irène Litvan, Kurt A Jellinger, M Verny   +2 more
exaly  

Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

Brain, 2012
Helen Ling, Andrew J Lees, Peter Brown
exaly  

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

Lancet, The, 1999
Anette Schrag, Yoav Ben-Shlomo, Niall P Quinn   +2 more
exaly  

Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy

JAMA Neurology
Ivan Martinez-Valbuena, Anthony E Lang, Gabor G Kovacs   +2 more
exaly  

18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy

Brain, 2017
Luca Passamonti, Patricia Vazquez Rodríguez, Young T Hong   +2 more
exaly  

Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications

Brain, 2000
Jaimie M Henderson, Glenda M Halliday
exaly